Name: Latest research reports of Lupin Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Falling Comet

1894.8000 -19.40 (-1.01%)

NSE Jul 10, 2025 15:31 PM

Volume: 2.1M

Lupin Ltd.

09 Nov 2024, 12:00AM

1894.80

-1.01%

Lupin (BUY): In-line quarter; EBITDAM guidance increased to 25%

Buy: Lupin Ltd.

Recommendation Target

BOB Capital Markets Ltd.

LPC's earnings were in line with our estimates but beat street's estimates. EBITDA margin was 23% in Q2FY25

BOB Capital Markets Ltd. released a Buy report for Lupin Ltd. with a price target of 2626.0 on 03 Jul, 2025.